PELEMED
PeLeMed is a drug development company working on the discovery of anti-cancer drugs. The company's innovative therapeutic candidates through type 1 kinase inhibitor development platform.
PELEMED
Industry:
Biotechnology Medical Therapeutics
Founded:
2020-01-01
Address:
Yeoksamdong, Seoul-t'ukpyolsi, South Korea
Country:
South Korea
Website Url:
http://www.pelemed.com
Total Employee:
11+
Status:
Active
Contact:
822-965-7977
Total Funding:
6.5 B KRW
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF WordPress Apache Wordpress Plugins Sitelinks Search Box Euro Organization Schema Sectigo SSL
Similar Organizations
Chroma Medicine
Chroma Medicine is a new genomic medicine company working on epigenetic editing.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
Current Employees Featured
Founder
Investors List
LSK Investment
LSK Investment investment in Series A - PeLeMed
Dt&Investment
Dt&Investment investment in Series A - PeLeMed
Daekyo Investment
Daekyo Investment investment in Series A - PeLeMed
Spring Camp
Spring Camp investment in Series A - PeLeMed
KDB Capital
KDB Capital investment in Series A - PeLeMed
SGI Venture Capital
SGI Venture Capital investment in Series A - PeLeMed
Official Site Inspections
http://www.pelemed.com
- Host name: 211.47.74.37
- IP address: 211.47.74.37
- Location: South Korea
- Latitude: 37.5112
- Longitude: 126.9741
- Timezone: Asia/Seoul
More informations about "PeLeMed"
aboutus â PeLeMed
PeLeMed is a company specializing in the development of global innovative anticancer and antiviral drugs based on precision drug design and artificial intelligence drug development platform technology. ... Organization âŚSee details»
PeLeMed â Pioneering Small Molocule Drugs Against Onclology âŚ
í ë ëŠë, ę¸ěąęł¨ěěąë°ąíëłěšëŁě ëą íě ě ě˝ íëł´ëŹźě§ íě´íëźě¸ ę°ë° ë°ě°¨See details»
Leadership â PeLeMed
M.S-Ph.D. : Korea Univ., Biomedical Science; Pin Therapeutics Inc., Executive Director of Bioscience division; Handok Co., Ltd., Head of New Drug R&D departmentSee details»
PeLeMed - Crunchbase Company Profile & Funding
Organization. PeLeMed . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. PeLeMed is a drug development company âŚSee details»
history â PeLeMed
PeLeMed founded (May) Certificate of Venture business (Sep) Moved into SEOUL BIOHUB (Nov) Headquarter: #108, Life Science-dong, 123, Cheomdangwagi-ro, Buk-gu, Gwangju, Republic âŚSee details»
Pelemed Co., Ltd. - Drug pipelines, Patents, Clinical trials - Synapse
Nov 1, 2024 Pelemed Co., Ltd. is a South Korean company located in Seoul that develops drugs for treatment of intractable cancer, neurological & immune diseases. It was founded in 2019. âŚSee details»
PeLeMed Company Profile 2024: Valuation, Funding & Investors
PeLeMed General Information Description. Developer of an anti-cancer drug intended to treat patients with incurable cancer and intractable carcinoma. The company's drug discovery âŚSee details»
PeLeMed - VentureRadar
" PeLeMed is a company specializing in the development of global innovative anticancer and antiviral drugs based on precision drug design and artificial intelligence drug development âŚSee details»
PeLeMed Company Profile | Gwangju, Gwangju, Republic Of Korea ...
Find company research, competitor information, contact details & financial data for PeLeMed of Gwangju, Gwangju. Get the latest business insights from Dun & Bradstreet.See details»
PeLeMed - Products, Competitors, Financials, Employees, âŚ
PeLeMed is a biopharmaceutical company focused on developing small molecule drugs for oncology and viral diseases. Use the CB Insights Platform to explore PeLeMed's full profile. âŚSee details»
PeLeMed - Crunchbase
PeLeMed is a drug development company working on the discovery of anti-cancer drugs.See details»
PeLeMed - Contacts, Employees, Board Members, Advisors & Alumni
Organization. PeLeMed . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 5. About. PeLeMed has 5 âŚSee details»
PeLeMed - Funding, Financials, Valuation & Investors - Crunchbase
PeLeMed is a drug development company working on the discovery of anti-cancer drugs. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. Resources. ... How âŚSee details»
research â PeLeMed
PeLeMed is driven to rapidly design and develop new cancer therapies that address unmet medical needs and help the patients who are refractory to conventional anti-cancer drugs that âŚSee details»
PLD-102 - Drug Targets, Indications, Patents - Synapse - Patsnap
PLD-102, Initially developed by Pelemed Co., Ltd., Now, its global highest R&D status is Phase 1, Therapeutic Areas: Neoplasms,Hemic and Lymphatic Diseases, Active Indication: Acute âŚSee details»
PeLeMed - Tech Stack, Apps, Patents & Trademarks - Crunchbase
PeLeMed is a drug development company working on the discovery of anti-cancer drugs.See details»
R&D â PeLeMed
Kinase Targeted Anti-cancer Drugs â Drug resistant mutations have been frequently evoked in the Gate Keeper Residue and Solvent Front Region within 1-2 years after the treatment to the âŚSee details»
PeLeMed | VentureRadar
PeLeMed is a company specializing in the development of global innovative anticancer and antiviral drugs based on precision drug design and artificial intelligence drug development âŚSee details»
PLD-104 - Drug Targets, Indications, Patents - Synapse
Indication Highest Phase Country/Location Organization Date; RET fusion-positive Non-Small Cell Lung Cancer: DiscoverySee details»
PLD-103 - Drug Targets, Indications, Patents - Synapse
PLD-103: a TEAD inhibitors Drug, Initially developed by Pelemed Co., Ltd., Now, its global highest R&D status is Discovery, Mechanism: TEAD inhibitors(TEA domain ...See details»